ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 12401 to 12423 of 39325 messages
Chat Pages: Latest  505  504  503  502  501  500  499  498  497  496  495  494  Older
DateSubjectAuthorDiscuss
22/10/2020
08:09
Added twice so far today. This is an absolute steal now.
someuwin
22/10/2020
08:09
Re realist195022 Oct '20 - 08:24 - 12193

"It seems the poor market reaction to both the initial oncology data and latterly the IBS trial results was the final straw. At least it has motivated the team to move quickly and position the business where they clearly know there is considerable investment interest."

I don't know realist, seems a little unlikely they cooked this up in the last two weeks after RNS Blautix, looks more like a dobble whammy which might turn out to be a triple or quadruple whammy in the very near future

thresholdbypass
22/10/2020
07:57
Perhaps Seres fell heavily yesterday (see chart in header) because they got wind of the fact that there was a new microbe company coming to NASDAQ to take their crown!
someuwin
22/10/2020
07:56
You are certifiable.
captain james t kirk
22/10/2020
07:56
.....seems like an option for the brain dead at this price;)
thefartingcommie
22/10/2020
07:53
I expect £10 a share by Q1 2021
I expect £100 a share by Q1 2022

the stigologist
22/10/2020
07:53
Interesting timing by those 2 hedge funds taking out 0.5% and 0.6% shorts in 4D over the last few weeks. A lower share price no doubt helped the US side in this deal.

Other than that it looks like a great deal.

loafofbread
22/10/2020
07:52
fantastic news. Forward looking company now. Should get a decent forum again
swallowsflysouth
22/10/2020
07:45
Intro video for US Investors #DDDD $LOAC $LBPS
the stigologist
22/10/2020
07:41
Up to $23 mn in potential warrant proceeds!!

Further good news on funding is likely over the coming weeks then.

techtrend
22/10/2020
07:40
blueblood22 Oct '20 - 08:15 - 12179 of 12200
0 0 0
Shows the markets don’t know all the time. £1.10 swap rate when we hit 88p yesterday.

.............................

A post worth picking out.

I agree.

And that is another feather in the company's hat.

realist1950
22/10/2020
07:36
Lots of manipulation going on as we clear the last of the small time flippers! AIM is so fickle. Today's announcement sets 4D on course for a huge re-rate over the coming months.. timing also clearly aligned with the 3 poster presentation in the US. Not to mention the additional £23m in warrant cash and the extra £2m 4D Mmgt have pumped in as part of the merger! A truly Stonking deal
trotterstrading
22/10/2020
07:36
maffs aint my best subject! I do get it; thx Mr Roper.

Recon this will tick up over several days as the rns sinks in.

amunro
22/10/2020
07:36
We're still on the cess-pit. A red finish would not be a surprise.
eeza
22/10/2020
07:35
This is a massive opportunity to buy at these low levels. Market hasn't fully grasped the disconnect between 4D and Seres Therapeutics yet. (Clue 4D arguably worth more than Seres even at this stage)
someuwin
22/10/2020
07:35
Myles McNulty
@MylesMcNulty
·
9m
Bought back into #DDDD on the back of today's news of the RTO onto NASDAQ, which I have been waiting for.

One need only consider another NASDAQ-listed Live Biotherapeutics Products play, Seres (MCRB) - now at ~$2.5bn mkt cap.

US investors are much more liberal!

Average ~107p.

showmethemoneyhoney01
22/10/2020
07:31
Hopefully a proactive interview will be done later. Always gives a good well answered interview does DP.
showmethemoneyhoney01
22/10/2020
07:28
The Story just begins, now just need a few more of my other stocks to mature quickly so I can pile more into here at anything below £2. Oh well never did get my 80p, but what's 80p or £2 when you're aiming for £75
katsy
22/10/2020
07:24
Good morning. (GOOD MORNING).

I will write a full summary of thoughts on this a little later only to say, for now, this is a very competent BOD - one that has proven it can move quickly and tenaciously within the clinic, and also do the same with regards to its finances and structure.

It seems the poor market reaction to both the initial oncology data and latterly the IBS trial results was the final straw. At least it has motivated the team to move quickly and position the business where they clearly know there is considerable investment interest.

As I have posted previously, there is a good level of expertise here in both camps....that of 'money men' - those who are at just the right age/experience and possess good levels of drive and energy, (AND who are very much invested), and, expertise - SECTOR LEADING expertise no less - within the actual clinic. It's a very nicely balanced company.

It seems to be so utterly lost on many over the past few days that this company is highly likely to announce something of great significance next month at the conference regarding oncology.....not to mention a likely partnering deal for Blautix before the end of the year.

I was pleased to add a fairly thick wad of shares yesterday....although the precise timing with regards to today's news was, I concede, sheer luck as I would be the first to admit that an update on NASDAQ was anticipated a little further off than this.

Hugely encouraging.

Rgds.

realist1950
22/10/2020
07:24
Gbp:usd fx rate and also where the stock issued on aim and nasdaq are same quantity. Doubtful they will be so it could be 1 nasdaq adr = 10 aim shares.

Then you do the maffs

mr roper
22/10/2020
07:23
4D are operating in an new and rapidly emerging therapeutic area and there's no doubt that the US markets embrace new technology much more readily, so a nasdaq listing makes sense. Having the Merck deal and collaboration under their belts will give 4D extra visibility too. Good stuff.

Love the ticker - LBPS (live biotherapeutics)

bermudashorts
22/10/2020
07:21
I am interested in how an aim price will track a nasdaq price. Anyone any experience on this?
amunro
22/10/2020
07:19
Now in Nasdaq should hit 160.0 soon
bag158s
Chat Pages: Latest  505  504  503  502  501  500  499  498  497  496  495  494  Older

Your Recent History

Delayed Upgrade Clock